Dishman Carbogen Amcis planning to raise funds via NCDS

25 May 2024 Evaluate

Dishman Carbogen Amcis is planning to raise funds by way of issuance of Non-Convertible Debentures (NCDs), by way of private placement, subject to such regulatory or statutory approvals as may be required. The meeting of the Board of Directors of the company will be held on May 30, 2024, inter alia, to consider, the same. 

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


Dishman Carbogen Amc Share Price

157.50 -7.60 (-4.60%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×